image
Healthcare - Biotechnology - NASDAQ - US
$ 1.84
-3.16 %
$ 138 M
Market Cap
-2.09
P/E
BALANCE SHEET
16.1 M ASSETS
-57.69%
4.19 M LIABILITIES
30.68%
11.9 M EQUITY
-65.85%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Context Therapeutics Inc.
image
Current Assets 16 M
Cash & Short-Term Investments 14.4 M
Receivables 0
Other Current Assets 1.6 M
Non-Current Assets 15.5 K
Long-Term Investments 0
PP&E 15.5 K
Other Non-Current Assets 0
Current Liabilities 4.19 M
Accounts Payable 2.38 M
Short-Term Debt 0
Other Current Liabilities 1.81 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 14.4 35.5 49.6 0.3 0.2
Short Term Investments 0 0 0 0 0
Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 1.6 2.4 3.2 8.67 K 13 K
Total Current Assets 16.0 37.9 51.3 0.3 0.2
PP&E 15.5 K 79.5 K 0 0 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 50.4 K 0 0
Other Long Term Assets 0 32.8 K 0 0.1 33.9 K
Other Assets 0 0 0 0 0
Total Assets 16.1 38.0 51.3 0.5 0.3
LIABILITIES
Accounts Payable 2.4 0.9 1.8 2.7 2.1
Short Term Debt 0 0.1 0 5.9 21.8
Other Current Liabilities 1.8 2.2 1.2 1.0 0.2
Total Current Liabilities 4.2 3.2 3.0 9.5 24.1
Long Term Debt 0 0 0 69 K 0
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0 0 0 7.8 0.1
Total Liabilities 4.2 3.2 3.0 17.4 24.2
EQUITY
Common Stock 16 K 16 K 16 K 332 324
Retained Earnings (68.1) (44.1) (29.3) (18.8) (25.4)
Other Accumulative Comprehensive Income/Loss 0 0 (51.3) (7.8) (0.1)
Total Equity 11.9 34.8 48.3 (16.9) (24.0)
Total Liabilities and Equity 16.1 38.0 51.3 0.5 0.3
SHARES OUTSTANDING
Common Shares Outstanding 16.0 16.0 16.0 11.0 11.0